AbbVie Inc.
- Stock
- Ticker ABBV
- ISIN US00287Y1091
- NYSE
Performance, volatility and drawdowns of AbbVie Inc. since 11/2016, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.
Performance
$10,000 grew to $71,213. Global equities (VT): $29,042.
Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.
Declines from the peak
Lowest point −45.1% in 08/2019, measured from the peak in 01/2018. It took 34 months to get back to the old peak.
Financial statements
Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures
| Quarter end | 12/2024 | 03/2025 | 06/2025 | 09/2025 | 12/2025 | 03/2026 | 06/2026 | 09/2026 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | 15,102 | 13,343 | 15,423 | 15,776 | 16,618 | 15,002 | 16,990 | 17,404 |
| Gross profit | 10,706 | 9,341 | 11,077 | 10,472 | 12,066 | 10,784 | 12,699 | 13,119 |
| Operating income | -1,490 | 3,733 | 4,894 | 1,904 | 4,544 | 3,990 | 6,432 | 6,267 |
| EBITDA | -1,284 | 3,914 | 5,080 | 2,096 | 4,747 | 4,178 | 6,626 | 6,459 |
| Net income | -22 | 1,286 | 938 | 186 | 1,816 | 695 | 3,613 | 4,218 |
| Earnings per share | -0.02 | 0.72 | 0.52 | 0.10 | 1.02 | 0.39 | 2.03 | 2.37 |
| Balance sheet | ||||||||
| Total assets | 135,161 | 136,165 | 137,182 | 133,898 | 133,960 | 136,463 | 135,115 | 147,680 |
| Liabilities | 131,797 | 134,703 | 137,320 | 136,497 | 137,188 | 143,075 | 141,003 | 152,218 |
| Equity | 3,325 | 1,420 | -183 | -2,642 | -3,270 | -6,656 | -5,935 | -4,583 |
| Cash | 5,524 | 5,175 | 6,467 | 5,629 | 5,229 | 9,391 | 6,569 | 10,774 |
| Long-term debt | 66,841 | – | – | – | 64,503 | – | – | – |
| Cash flow | ||||||||
| Operating cash flow | 7,048 | 1,635 | 5,153 | 7,024 | 5,218 | 3,829 | 3,436 | 7,606 |
| Capital expenditure | -291 | -235 | -269 | -381 | -329 | -265 | -322 | -301 |
| Free cash flow | 6,757 | 1,400 | 4,884 | 6,643 | 4,889 | 3,564 | 3,114 | 7,305 |
Value it:DCF calculatorMultiples calculator
Annual returns
Best year 2017 at +60.1%, weakest 2018 at −1.0%. 7 of 9 full years were positive. * partial year.
Quarterly reports
Filing date with the SEC and earnings per share of the quarter
| Day | Earnings per share |
|---|---|
| 3 Nov 2026 | $2.37 |
| 3 Aug 2026 | $2.03 |
| 8 May 2026 | $0.39 |
| 20 Feb 2026 | $1.02 |
| 4 Nov 2025 | $0.10 |
| 4 Aug 2025 | $0.52 |
| 9 May 2025 | $0.72 |
| 14 Feb 2025 | −$0.02 |
| 4 Nov 2024 | $0.88 |
| 7 Aug 2024 | $0.77 |
| 3 May 2024 | $0.77 |
| 20 Feb 2024 | $0.46 |
Key metrics
Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.
Valuation
- Market cap
- €458bn
- Market cap in trading currency
- $506bn
- Enterprise value
- $495bn
- P/E
- 49.3
- P/S
- 7.66
- P/B
- –
- EV/Sales
- 7.50
- EV/EBITDA
- 22.5
- Earnings yield
- 2.0%
- FCF yield
- 3.7%
Results (last four quarters)
- Revenue
- $66.0bn
- Gross profit
- $48.7bn
- EBITDA
- $22.0bn
- Net income
- $10.3bn
- Earnings per share
- $5.81
- Revenue per share
- $37.35
- Revenue growth
- +10.3%
- Earnings growth
- +2,167.7%
Profitability
- Gross margin
- 73.7%
- Operating margin
- 32.2%
- Net margin
- 15.7%
- Return on equity
- –
- Return on assets
- 7.0%
Balance sheet and cash flow
- Cash
- $10.8bn
- Cash per share
- $6.10
- Financial debt
- $0
- Debt/equity %
- –
- Current ratio
- 0.87
- Book value per share
- −$2.59
- Operating cash flow
- $20.1bn
- Free cash flow
- $18.9bn
Dividend
- Dividend yield
- 2.42%
- Dividend (12 months)
- $6.92
- Yield (12 months)
- 2.42%
- Payout ratio
- 119%
- Ex-dividend date
- 15 Oct 2026
Shares and trading
- Shares outstanding
- 1.77bn
- Volume
- 8.67m
- Avg. volume 3 months
- 4.80m
- Relative volume
- 1.8
Price and technicals
- Price
- $286.20
- 1 day
- +0.9%
- 52-week high
- $295.03
- 52-week low
- $197.38
- Distance to 52-week high
- −3.0%
- Distance to 52-week low
- +45.0%
- Distance to 50-day line
- +2.6%
- Distance to 200-day line
- +18.0%
- RSI (14)
- 49
- Volatility 1M
- 20.7%
Performance
- 1 week
- −3.0%
- 1 month
- +0.4%
- 3 months
- +8.2%
- 6 months
- +32.7%
- YTD
- +25.3%
- 1 year
- +22.9%
Dates
- Fiscal year end
- 31 Dec 2025
- Most recent quarter
- 30 Sep 2026
Frequently asked questions
How has ABBV performed since 11/2016?
$10,000 grew to $71,213 by 20 Nov 2026, which is +21.7% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.
How volatile is ABBV?
Volatility was 25.4% per year, measured on monthly returns. The largest decline from a peak was −45.1%, with the low in 08/2019.
How does ABBV compare with a broad equity ETF?
Over the same period Global equities (VT) returned +11.3% per year at 15.1% volatility, ABBV returned +21.7% at 25.4%. The correlation of monthly returns was 0.34; 1 would mean they moved in lockstep.
Which currency are the figures in?
In US dollars, the currency of the US listing.